Sanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback